S&P 500   3,297.66 (+0.81%)
DOW   26,669.92 (+0.91%)
QQQ   269.60 (+1.43%)
AAPL   436.27 (+2.64%)
MSFT   214.97 (+4.86%)
FB   254.57 (+0.35%)
GOOGL   1,477.51 (-0.70%)
AMZN   3,123.81 (-1.29%)
NVDA   442.96 (+4.33%)
CGC   18.35 (+0.38%)
BABA   257.00 (+2.38%)
TSLA   1,504.33 (+5.14%)
MU   50.40 (+0.68%)
GE   6.15 (+1.32%)
AMD   77.98 (+0.71%)
T   29.51 (-0.24%)
F   6.68 (+1.06%)
ACB   10.15 (-0.39%)
GILD   71.83 (+3.31%)
NFLX   502.95 (+2.88%)
DIS   116.45 (-0.42%)
BAC   25.06 (+0.72%)
BA   162.15 (+2.63%)
S&P 500   3,297.66 (+0.81%)
DOW   26,669.92 (+0.91%)
QQQ   269.60 (+1.43%)
AAPL   436.27 (+2.64%)
MSFT   214.97 (+4.86%)
FB   254.57 (+0.35%)
GOOGL   1,477.51 (-0.70%)
AMZN   3,123.81 (-1.29%)
NVDA   442.96 (+4.33%)
CGC   18.35 (+0.38%)
BABA   257.00 (+2.38%)
TSLA   1,504.33 (+5.14%)
MU   50.40 (+0.68%)
GE   6.15 (+1.32%)
AMD   77.98 (+0.71%)
T   29.51 (-0.24%)
F   6.68 (+1.06%)
ACB   10.15 (-0.39%)
GILD   71.83 (+3.31%)
NFLX   502.95 (+2.88%)
DIS   116.45 (-0.42%)
BAC   25.06 (+0.72%)
BA   162.15 (+2.63%)
S&P 500   3,297.66 (+0.81%)
DOW   26,669.92 (+0.91%)
QQQ   269.60 (+1.43%)
AAPL   436.27 (+2.64%)
MSFT   214.97 (+4.86%)
FB   254.57 (+0.35%)
GOOGL   1,477.51 (-0.70%)
AMZN   3,123.81 (-1.29%)
NVDA   442.96 (+4.33%)
CGC   18.35 (+0.38%)
BABA   257.00 (+2.38%)
TSLA   1,504.33 (+5.14%)
MU   50.40 (+0.68%)
GE   6.15 (+1.32%)
AMD   77.98 (+0.71%)
T   29.51 (-0.24%)
F   6.68 (+1.06%)
ACB   10.15 (-0.39%)
GILD   71.83 (+3.31%)
NFLX   502.95 (+2.88%)
DIS   116.45 (-0.42%)
BAC   25.06 (+0.72%)
BA   162.15 (+2.63%)
S&P 500   3,297.66 (+0.81%)
DOW   26,669.92 (+0.91%)
QQQ   269.60 (+1.43%)
AAPL   436.27 (+2.64%)
MSFT   214.97 (+4.86%)
FB   254.57 (+0.35%)
GOOGL   1,477.51 (-0.70%)
AMZN   3,123.81 (-1.29%)
NVDA   442.96 (+4.33%)
CGC   18.35 (+0.38%)
BABA   257.00 (+2.38%)
TSLA   1,504.33 (+5.14%)
MU   50.40 (+0.68%)
GE   6.15 (+1.32%)
AMD   77.98 (+0.71%)
T   29.51 (-0.24%)
F   6.68 (+1.06%)
ACB   10.15 (-0.39%)
GILD   71.83 (+3.31%)
NFLX   502.95 (+2.88%)
DIS   116.45 (-0.42%)
BAC   25.06 (+0.72%)
BA   162.15 (+2.63%)
Log in

NYSE:NUSNu Skin Enterprises Stock Price, Forecast & News

$45.15
+0.30 (+0.67 %)
(As of 08/3/2020 01:39 PM ET)
Add
Compare
Today's Range
$44.20
Now: $45.15
$45.20
50-Day Range
$35.92
MA: $41.85
$48.02
52-Week Range
$12.31
Now: $45.15
$48.61
Volume11,264 shs
Average Volume528,406 shs
Market Capitalization$2.34 billion
P/E Ratio16.72
Dividend Yield3.34%
Beta1.25
Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Read More
Nu Skin Enterprises logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.6Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.24 out of 5 stars


Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
CUSIP67018T10
Phone801-345-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.42 billion
Cash Flow$4.53 per share
Book Value$15.74 per share

Profitability

Net Income$173.55 million

Miscellaneous

Employees4,900
Market Cap$2.34 billion
Next Earnings Date8/5/2020 (Confirmed)
OptionableOptionable
$45.15
+0.30 (+0.67 %)
(As of 08/3/2020 01:39 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

How has Nu Skin Enterprises' stock been impacted by COVID-19 (Coronavirus)?

Nu Skin Enterprises' stock was trading at $21.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NUS shares have increased by 114.4% and is now trading at $45.15.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Nu Skin Enterprises?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Nu Skin Enterprises
.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020.
View our earnings forecast for Nu Skin Enterprises
.

How can I listen to Nu Skin Enterprises' earnings call?

Nu Skin Enterprises will be holding an earnings conference call on Wednesday, August 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) issued its quarterly earnings data on Wednesday, May, 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.25 by $0.11. The company had revenue of $518.03 million for the quarter, compared to the consensus estimate of $477.01 million. Nu Skin Enterprises had a return on equity of 17.91% and a net margin of 6.49%. Nu Skin Enterprises's revenue was down 16.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.77 EPS.
View Nu Skin Enterprises' earnings history
.

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises declared a quarterly dividend on Wednesday, May 6th. Investors of record on Friday, May 29th will be given a dividend of $0.375 per share on Wednesday, June 10th. This represents a $1.50 annualized dividend and a yield of 3.32%. The ex-dividend date is Thursday, May 28th.
View Nu Skin Enterprises' dividend history
.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises updated its second quarter 2020 After-Hours earnings guidance on Wednesday, July, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $603-608 million, compared to the consensus revenue estimate of $540.85 million.

What price target have analysts set for NUS?

8 analysts have issued 1 year price targets for Nu Skin Enterprises' shares. Their forecasts range from $30.00 to $70.00. On average, they expect Nu Skin Enterprises' stock price to reach $45.14 in the next twelve months. This suggests that the stock has a possible downside of 0.0%.
View analysts' price targets for Nu Skin Enterprises
.

What are Wall Street analysts saying about Nu Skin Enterprises stock?

Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
  • 1. According to Zacks Investment Research, "Nu Skin’s shares have underperformed the industry in the past six months. Headwinds in Mainland China, a soft view for 2020 and currency fluctuations are prime deterrents. The recently completed 100-day government campaign in Mainland China to inspect offerings of the nutrition and direct sales industry led to adversities like limited sales meetings. This took a toll on the company’s third-quarter 2019 results, with revenues and earnings declining year over year. The company also issued a soft view for the fourth quarter and 2020, wherein adverse impacts from currency movements are likely to persist. Nevertheless, the company is on track with product launches and programs to strengthen sales leaders in Mainland China. Also, the company is committed toward boosting customer base, which grew 4% in the third quarter." (11/11/2019)
  • 2. Pivotal Research analysts commented, "We suspect that NUS management has taken an axe to the outlook to avoid having to cut again." (8/7/2019)

Has Nu Skin Enterprises been receiving favorable news coverage?

News coverage about NUS stock has been trending negative recently, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Nu Skin Enterprises earned a news sentiment score of -2.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days.
View the latest news about Nu Skin Enterprises
.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 2,050,000 shares, an increase of 10.2% from the June 30th total of 1,860,000 shares. Based on an average trading volume of 802,000 shares, the days-to-cover ratio is currently 2.6 days. Currently, 4.2% of the company's stock are sold short.
View Nu Skin Enterprises' Current Options Chain
.

Who are some of Nu Skin Enterprises' key competitors?

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), Marathon Petroleum (MPC), Herbalife Nutrition (HLF), Baidu (BIDU), Las Vegas Sands (LVS), Netflix (NFLX), Booking (BKNG), Alphabet (GOOG) and Mastercard (MA).

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the following people:
  • Mr. Steven J. Lund, Exec. Chairman (Age 66)
  • Mr. Ritch N. Wood, CEO & Director (Age 53)
  • Mr. Ryan S. Napierski, Pres (Age 45)
  • Mr. Mark H. Lawrence, Exec. VP & CFO (Age 49)
  • Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 66)

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a number of retail and institutional investors. Top institutional investors include First Trust Advisors LP (0.97%), Mackay Shields LLC (0.28%), Empowered Funds LLC (0.13%), Stone Ridge Asset Management LLC (0.13%), Empirical Finance LLC (0.05%) and Strs Ohio (0.04%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Edwina D Woodbury, Foulis Greg, Joseph Y Chang, Ritch N Wood and Ryan S Napierski.
View institutional ownership trends for Nu Skin Enterprises
.

Which institutional investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, First Quadrant L P CA, Louisiana State Employees Retirement System, and Oregon Public Employees Retirement Fund.
View insider buying and selling activity for Nu Skin Enterprises
.

Which institutional investors are buying Nu Skin Enterprises stock?

NUS stock was acquired by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Empowered Funds LLC, Mackay Shields LLC, Strs Ohio, Parallel Advisors LLC, Alpha Windward LLC, Sciencast Management LP, and Dupont Capital Management Corp.
View insider buying and selling activity for Nu Skin Enterprises
.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $45.15.

How big of a company is Nu Skin Enterprises?

Nu Skin Enterprises has a market capitalization of $2.34 billion and generates $2.42 billion in revenue each year. The company earns $173.55 million in net income (profit) each year or $3.10 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe.

What is Nu Skin Enterprises' official website?

The official website for Nu Skin Enterprises is www.nuskinenterprises.com.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]

This page was last updated on 8/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.